8.13
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Athenex Inc | ATNX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.0% | 8.13 | 0.00 | 0.00 | 0.00 | 8.13 | 04:00:00 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 6.00 | 14.36 | 8.36 | 58.22% | - | - |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 8.13 | USD |
Athenex Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 663.63M | 81.63M | $ -117.44M | -1.68 | - | 74.19M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 19.00 | 9.10% |
Athenex News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ATNX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 8.20 | 8.20 | 6.96 | 7.75 | 596,537 | -0.07 | -0.85% |
| 1 Month | 10.47 | 10.60 | 5.63 | 7.75 | 912,573 | -2.34 | -22.35% |
| 3 Months | 14.99 | 15.73 | 5.63 | 10.78 | 680,178 | -6.86 | -45.76% |
| 6 Months | 12.14 | 22.00 | 5.63 | 12.67 | 941,057 | -4.01 | -33.03% |
| 1 Year | 11.62 | 22.00 | 5.63 | 13.80 | 778,656 | -3.49 | -30.03% |
| 3 Years | 12.00 | 22.00 | 5.63 | 14.48 | 459,140 | -3.87 | -32.25% |
| 5 Years | 12.00 | 22.00 | 5.63 | 14.48 | 459,140 | -3.87 | -32.25% |
Athenex Description
| Athenex Inc is a global biopharmaceutical company. It is dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer. The company's operating segment includes the Oncology Innovation Platform; Global Supply Chain Platform and Commercial Platform. It generates maximum revenue from the Commercial Platform segment. Commercial Platform segment includes APD, which focuses on the manufacturing, distribution, and sales of specialty pharmaceuticals. Geographically, it derives a majority of revenue from the United States and also has a presence in Spain; Austria; India; China; the United Kingdom and Other foreign countries. |
